Previously traded on OTC, ChromaDex Corporation (NASDAQ:CDXC) is in the natural products business: a bioscience company focusing on healthy aging. The company operates in three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. The firm's research endeavors organize primarily around nicotinamide adenine dinucleotide (NAD+)/. Finished dietary supplement products - containing the firm's proprietary ingredients -- are provided irectly to consumers, as well as to distributors. The firm also develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of other consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. Also offered as analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries.